Thermo Fisher Scientific enjoys record-breaking close to 2013

Thermo Fisher Scientific has announced its financial results for the 2013 full-year period, during which it achieved a 12-month revenue total of $13.09 billion (8.03 billion pounds).

This represented a five percent year-on-year increase, with its strong performance for the year confirmed by a record-breaking fourth quarter revenue figure of $3.47 billion in which all three of its business segments reported solid growth.

New products were launched for customers in the research, bioproduction, specialty diagnostics and applied sectors, while in emerging markets, the firm was able to meet demand for better air quality, safer food supplies and diagnostic aids.

In 2014, the company will add a fourth reporting segment to its business following the completion of the takeover of Life Technologies in a deal worth around $13.6 billion.

The acquisition was finalised this week and will allow Thermo Fisher to further augment its expertise in the field of genomics, proteomics and specialty diagnostics.

Marc Casper, president and chief executive officer of Thermo Fisher Scientific, said: "These results demonstrate the success of our growth strategy and our ability to further differentiate Thermo Fisher in the markets we serve."